{"id":8094,"date":"2013-10-07T00:00:00","date_gmt":"2013-10-06T22:00:00","guid":{"rendered":"https:\/\/idibell.cat\/blog\/2015\/09\/23\/lassociacio-alba-perez-financa-un-projecte-de-lidibell-per-a-la-recerca-del-sarcoma-dewing\/"},"modified":"2021-11-17T16:17:44","modified_gmt":"2021-11-17T15:17:44","slug":"lassociacio-alba-perez-financa-un-projecte-de-lidibell-per-a-la-recerca-del-sarcoma-dewing","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2013\/10\/lassociacio-alba-perez-financa-un-projecte-de-lidibell-per-a-la-recerca-del-sarcoma-dewing\/","title":{"rendered":"L\u2019Associaci\u00f3 Alba P\u00e9rez finan\u00e7a un projecte de l\u2019IDIBELL per a la recerca del sarcoma d\u2019Ewing"},"content":{"rendered":"

L’Institut d’Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) i l’Associaci\u00f3 Alba P\u00e9rez contra el c\u00e0ncer infantil han signat un conveni per a financer amb 200.000 euros un projecte d’investigaci\u00f3 dirigit pel cap de grup d’investigaci\u00f3 en sarcomes Oscar Mart\u00ednez-Tirado que t\u00e9 com a objectiu trobar nous tractaments contra el sarcoma d’Ewing.<\/p>\n

El sarcoma d’Ewing \u00e9s el segon c\u00e0ncer d’os m\u00e9s com\u00fa i afecta a nens i joves. Actualment, si es diagnostica a temps i no presenta met\u00e0stasi, es pot curar en el 80% dels casos per\u00f2 entre el 25% i el 30% dels casos es diagnostica quan existeixi met\u00e0stasi i llavors la superviv\u00e8ncia baixa fins al 30%.<\/p>\n

L’Associaci\u00f3 Alba P\u00e9rez<\/strong><\/p>\n

A l’Alba li van diagnosticar sarcoma d’Ewing amb cinc mesos. Des d’aleshores, el seu pare Rafa P\u00e9rez no ha deixat de lluitar per recaptar fons per a la investigaci\u00f3 d’aquest c\u00e0ncer infantil. Va fundar l’associaci\u00f3 Alba P\u00e9rez contra el c\u00e0ncer infantil que organitza actes ben\u00e8fics i que t\u00e9 com a objectiu ajudar a la investigaci\u00f3 de nous tractaments contra el sarcoma d’Ewing, el segon c\u00e0ncer d’ossos m\u00e9s com\u00fa i que afecta nens i joves.<\/p>\n

Despr\u00e9s de 5 anys de lluita, l’Alba va morir l’1 d’agost passat. Tot i aix\u00f2, Rafa vol continuar la batalla contra aquest c\u00e0ncer \u201cja no ho faig per la meva filla sin\u00f3 perqu\u00e8 cap nen hagi de passar pel que va passar ella\u201d.<\/p>\n

La investigaci\u00f3 de nous tractaments<\/strong><\/p>\n

Aquest estiu un amic li va enviar una not\u00edcia que havia vist publicada al diari. Un equip de recerca de l?IDIBELL havia publicat un estudi sobre l’efecte d’un antibi\u00f2tic per tractar el sarcoma d’Ewing. Es tractava nom\u00e9s d’un estudi inicial i la not\u00edcia deixava clar que aquest antibi\u00f2tic no es podria fer servir en humans. Tot i aix\u00ed, Rafa P\u00e9rez es va posar en contacte amb el cap del grup de recerca en sarcomes de l’IDIBELL, \u00d2scar Mart\u00ednez-Tirado.<\/p>\n

De seguida van connectar i es va anar forjant el projecte que ara neix. L’associaci\u00f3 finan\u00e7ar\u00e0 amb 200.000 euros el projecte de Mart\u00ednez-Tirado per buscar un tractament per al sarcoma d’Ewing. El dilluns 30 de setembre es va signar el conveni i el 2 d’octubre es va fer entrega del tal\u00f3 durant el sopar ben\u00e8fic en honor a Alba.<\/p>\n","protected":false},"excerpt":{"rendered":"

L’Institut d’Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) i l’Associaci\u00f3 Alba P\u00e9rez contra el c\u00e0ncer infantil han signat un conveni per a financer amb 200.000 euros un projecte d’investigaci\u00f3 dirigit pel cap de grup d’investigaci\u00f3 en sarcomes Oscar Mart\u00ednez-Tirado que t\u00e9 com a objectiu trobar nous tractaments contra el sarcoma d’Ewing. El sarcoma d’Ewing \u00e9s el segon […]<\/p>\n","protected":false},"author":6,"featured_media":19738,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[1,332,447,452,398],"tags":[],"publishpress_future_action":{"enabled":false,"date":"2024-05-09 21:24:18","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/8094"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=8094"}],"version-history":[{"count":3,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/8094\/revisions"}],"predecessor-version":[{"id":19740,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/8094\/revisions\/19740"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/19738"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=8094"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=8094"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=8094"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}